Spots Global Cancer Trial Database for vincristine
Every month we try and update this database with for vincristine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin | NCT00993044 | Refractory Soli... | Irinotecan Vincristine Temozolomide Bevacizumab | 12 Months - 20 Years | Children's Hospital Los Angeles | |
| Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) | NCT00450385 | Lymphoma | Rituximab Cyclophosphamid... Doxorubicin Prednisone Vincristine | 18 Years - 120 Years | University of Miami | |
| Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma | NCT00335140 | Lymphoma | Rituximab Cytarabine Dexamethasone Leucovorin Methotrexate Procarbazine Vincristine | 18 Years - | Eastern Cooperative Oncology Group | |
| A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only | NCT00451178 | Lymphoma | enzastaurin rituximab cyclophosphamid... doxorubicin vincristine prednisone | 18 Years - | Eli Lilly and Company | |
| A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia | NCT00001689 | Acute Lymphocyt... Leukemia | Vincristine | - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | NCT00026208 | Lymphoma, Hodgk... Lymphoma Hodgkin Disease Lymphoma: Hodgk... | Vincristine Cyclophosphamid... Doxorubicin Prednisone Bleomycin Etoposide Low-dose radiot... | 18 Years - 70 Years | Stanford University | |
| RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor | NCT03536039 | Lymphoma, Large... | NGR-hTNF RITUXIMAB Doxorubicin Cyclophosphamid... Vincristine Prednisone | 18 Years - 80 Years | IRCCS San Raffaele | |
| A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma | NCT01569750 | CD20-positive B... | Part 1, Cohort ... Part 1, Cohort ... Part 1, Cohort ... Part 2, Cohort ... Part 2, Cohort ... | 18 Years - | Janssen Research & Development, LLC | |
| NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | NCT01451515 | Lymphoblastic L... | Prednisone Vincristine Daunorubicin PEG-asparaginas... Erwinia asparag... Doxorubicin Cyclophosphamid... Cytarabine Thioguanine Clofarabine Methotrexate Mercaptopurine Dexamethasone Hydrocortisone Etoposide | - 21 Years | St. Jude Children's Research Hospital | |
| Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) | NCT06210750 | T Acute Lymphob... T Lymphoblastic... | Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Calaspargase Pe... Computed Tomogr... Cyclophosphamid... Cytarabine Daunorubicin Dexamethasone Doxorubicin Echocardiograph... Lumbar Puncture Mercaptopurine Methotrexate Multigated Acqu... Navitoclax Nelarabine Pegaspargase Positron Emissi... Thioguanine Venetoclax Vincristine X-Ray Imaging | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma | NCT02455245 | Low Grade Gliom... | Carboplatin Vincristine | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| A Study in Adults With Untreated Acute Lymphoblastic Leukemia | NCT00136435 | Acute Lymphobla... | prednisone doxorubicin vincristine methotrexate asparaginase dexamethasone cranial radiati... leucovorin cytarabine hydrocortisone 6-mercaptopurin... e. coli L-aspar... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
| Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | NCT00613457 | Leukemia | dexamethasone asparaginase Asparaginase cyclophosphamid... cytarabine daunorubicin doxorubicin Etoposide Ifosfamide mercaptopurine Methotrexate prednisone thioguanine Vincristine Vindesine | 1 Year - 17 Years | Associazione Italiana Ematologia Oncologia Pediatrica | |
| Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia | NCT05453500 | B Acute Lymphob... | Bone Marrow Asp... Cyclophosphamid... Doxorubicin Etoposide Prednisone Rituximab Tafasitamab Vincristine | 18 Years - | University of Washington | |
| Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) | NCT02568683 | Non-Hodgkin Lym... | Entospletinib Vincristine | 18 Years - | Gilead Sciences | |
| R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL | NCT01148446 | Elderly Patient... Diffuse Large B... | Cyclophosphamid... Cyclophosphamid... Doxorubicin Vincristine Prednisone Prednisone Epirubicin Vinblastine Rituximab G-CSF | 66 Years - 80 Years | Fondazione Italiana Linfomi - ETS | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | NCT00000987 | Sarcoma, Kaposi HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Zidovudine | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| HD21 for Advanced Stages | NCT02661503 | Classical Hodgk... | Bleomycin Etoposide Doxorubicin Cyclophosphamid... Vincristine Procarbazine Prednisone Brentuximab Ved... Dacarbazine Dexamethasone | 18 Years - 60 Years | University of Cologne | |
| The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission. | NCT05990985 | Diffuse Large B... | Mitoxantrone hy... RiTUXimab Injec... Cyclophosphamid Vincristine Prednisolone | 18 Years - | The First Hospital of Jilin University | |
| Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies | NCT00718757 | Non-Hodgkins Ly... Hodgkin's Disea... Acute Lymphobla... | Dexamethasone Irinotecan Vincristine | - 21 Years | St. Jude Children's Research Hospital | |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 | NCT03286634 | Down Syndrome Acute Lymphobla... Childhood Cance... | Daunorubicin Prednisolone Vincristine Epirubicin E-coli L-aspara... 6-Mercaptopurin... Methotrexate Hydrocortisone Cytarabine Cyclophosphamid... | 0 Years - 20 Years | National Hospital Organization Nagoya Medical Center | |
| Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A | NCT02406092 | Non-Hodgkin Lym... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisone Fludarabine | 18 Years - 80 Years | Hoffmann-La Roche | |
| Treatment for Classical Hodgkin Lymphoma in Children and Adolescents | NCT02797717 | Classical Hodgk... | Radiotherapy: Vincristine Etoposide Prednisone Doxorubicin Dacarbazine Cyclophosphamid... | 1 Month - 18 Years | Rabin Medical Center | |
| A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) | NCT06401330 | Stage I Kidney ... Stage II Kidney... Stage III Kidne... Stage IV Kidney... | Bone Scan Carboplatin Computed Tomogr... Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Magnetic Resona... Nephrectomy Patient Observa... Positron Emissi... Ultrasound Imag... Vincristine X-Ray Imaging | - 30 Years | Children's Oncology Group | |
| PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma | NCT00054665 | B-Cell Lymphoma | PS-341 Etoposide Doxorubicin Vincristine Cyclophosphamid... Prednisone Filgrastim | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma | NCT04884035 | Lymphoma, B-Cel... | CC-220 Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisone CC-99282 Polatuzumab ved... Rituximab | 18 Years - | Celgene | |
| Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia | NCT01887587 | Relapsed or Ref... Relapsed or Ref... Mixed Phenotype... | MLN9708 Vincristine Doxorubicin Dexamethasone | 18 Years - | Medical College of Wisconsin | |
| Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia | NCT02981628 | Recurrent B Acu... Recurrent B Lym... Refractory B Ac... Refractory B Ly... | Asparaginase Er... Biospecimen Col... Bone Marrow Asp... Calaspargase Pe... Cyclophosphamid... Cytarabine Diagnostic Imag... Inotuzumab Ozog... Leucovorin Calc... Lumbar Puncture Methotrexate Pegaspargase Vincristine | 1 Year - 21 Years | Children's Oncology Group | |
| Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma | NCT03952572 | Peripheral T-ce... | Cyclophosphamid... pegylated lipos... Vincristine Prednisone Doxorubicin | 18 Years - 75 Years | Peking University | |
| Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | NCT03860844 | Acute Lymphobla... Acute Myeloid L... | Isatuximab Dexamethasone o... Fludarabine Cytarabine Liposomal dauno... Daunorubicin (n... Idarubicin Filgrastim or e... Mitoxantrone Doxorubicin Vincristine Pegaspargase (P... Cyclophosphamid... Etoposide Methotrexate L - Asparginase Hydroxyurea L - Asparaginas... | 28 Days - 17 Years | Sanofi | |
| Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | NCT02101853 | Recurrent B Acu... | Allogeneic Hema... Asparaginase Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Etoposide Leucovorin Calc... Mercaptopurine Methotrexate Mitoxantrone Mitoxantrone Hy... Pegaspargase Pharmacological... Radiation Thera... Therapeutic Hyd... Thioguanine Vincristine Vincristine Sul... | 1 Year - 31 Years | National Cancer Institute (NCI) | |
| Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients | NCT03617432 | Experimental Tu... | Chidamide Cyclophosphamid... Doxorubicin Vincristine Etoposide Prednisone | 18 Years - 70 Years | Peking University | |
| A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma | NCT03758989 | DLBCL | Rituximab Predn... Cyclophosphamid... Doxorubicin Vincristine Prednisone | 18 Years - | University of Rochester | |
| Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma | NCT05605899 | High-risk Large... | Axicabtagene Ci... Cyclophosphamid... Fludarabine Etoposide Rituximab Doxorubicin Vincristine Prednisone | 18 Years - | Gilead Sciences | |
| Fosaprepitant in Patients Receiving Ifosfamide-based Regimen | NCT01490060 | Sarcoma Chemotherapy-in... Effects of Chem... Adverse Effects... | Fosaprepitant Dexamethasone 5HT3 receptor a... Ifosfamide-base... Doxorubicin Mesna Ifosfamide Vincristine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | NCT00190528 | Cervical Neopla... | neoadjuvant che... radical hystere... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
| PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years | NCT01358201 | Acute Lymphobla... | vINCRISTINE Dexamethasone Methotrexate Cytosine arabin... | 55 Years - | PETHEMA Foundation | |
| RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor | NCT03536039 | Lymphoma, Large... | NGR-hTNF RITUXIMAB Doxorubicin Cyclophosphamid... Vincristine Prednisone | 18 Years - 80 Years | IRCCS San Raffaele | |
| Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | NCT00215943 | Multiple Myelom... | zoledronic acid dexamethasone thalidomide vincristine adriamycin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors | NCT00786669 | Solid Tumor | Bevacizumab Temozolomide Vincristine Irinotecan Cefixime | 1 Year - 30 Years | Children's Hospital Medical Center, Cincinnati | |
| A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma | NCT01974440 | Lymphoma | Bendamustine Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisone PCI-32765 (Ibru... Placebo | 18 Years - | Janssen Research & Development, LLC | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A | NCT01858922 | Hodgkin Disease | ABVE-PC DECA | - | Baylor College of Medicine | |
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas | NCT01445535 | T-Cell Peripher... Gamma Delta Hep... Subcutaneous Pa... NK T-Cell Lymph... | Rituximab Etoposide Siplizumab Prednisone Vincristine Cyclophosphamid... Doxorubicin | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | NCT03564704 | Leukemia Leukemia, Acute Adult Lymphobla... Leukemia, Lymph... Leukemia, T Cel... Adult Acute Lym... Lymphoblastic L... Lymphoblastic L... | Dexamethasone vincristine Cyclophosphamid... Idarubicin Pegaspargase Adriamycin Methotrexate 6-mercaptopurin... Etoposide Cytarabine Bone marrow asp... Intrathecal inj... Radiation thera... NGS allogeneic hema... Flow-MRD FISH Flow immunophen... Karyotyping Chidamide PET-CT scan | 14 Years - 55 Years | Nanfang Hospital, Southern Medical University | |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A | NCT01858922 | Hodgkin Disease | ABVE-PC DECA | - | Baylor College of Medicine | |
| GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma | NCT01659099 | Diffuse Large B... | GA101 Rituximab Doxorubicin Cyclophosphamid... Prednisone Bleomycin Vindesin Vincristine | 18 Years - 60 Years | The Lymphoma Academic Research Organisation | |
| S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00109837 | Leukemia | filgrastim cyclophosphamid... cytarabine daunorubicin dexamethasone doxorubicin leucovorin mercaptopurine methotrexate mitoxantrone Asparaginase prednisone thioguanine vincristine radiation thera... allopurinol bactrim | 18 Years - 64 Years | SWOG Cancer Research Network | |
| Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | NCT02228512 | Large Cell Lymp... Primary Effusio... | Pomalidomide Rituximab Prednisone Etoposide Doxorubicin Vincristine Cyclophosphamid... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT05032183 | Recurrent Adult... Recurrent B Acu... Recurrent T Acu... Refractory B Ac... Refractory Lymp... Refractory T Ac... | Cyclophosphamid... Cytarabine Dexamethasone Filgrastim-sndz Leucovorin Mercaptopurine Mesna Methotrexate Pegfilgrastim Prednisone Rituximab Tagraxofusp-erz... Vincristine | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Brentuximab for Newly Diagnosed Hodgkin Disease | NCT02398240 | Hodgkin Lymphom... | Brentuximab Ved... Doxorubicin Vincristine Rituximab | 1 Year - 29 Years | New York Medical College | |
| Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy | NCT05848765 | Relapsed Follic... Refractory Foll... | Epcoritamab Lenalidomide Rituximab Obinutuzumab Bendamustine Vincristine Doxorubicin Cyclophosphamid... Prednisone Investigation a... Investigation a... | 18 Years - | University of Birmingham | |
| Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers | NCT00051311 | Hematologic Neo... | Stem cell trans... Fludarabine Cyclophosphamid... Etoposide Doxorubicin Vincristine Prednisone Methotrexate Cyclosporine Apheresis | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors | NCT02684058 | Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Ipon... | Dabrafenib trametinib Carboplatin Vincristine | 12 Months - 17 Years | Novartis | |
| Adult ALL Treatment at Diagnosis | NCT00537550 | Leukemia, Lymph... | Vincristine Vincristin, Dau... | 14 Years - 60 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL | NCT00379574 | Lymphoma, Large... Lymphoma, B-Cel... | Bortezomib Cyclophosphamid... Doxorubicin Vincristine Prednisolone Lenograstim | 15 Years - 70 Years | Asan Medical Center | |
| Prospective Study on HIV-related Hodgkin Lymphoma | NCT01468740 | HIV-associated ... | Doxorubicin Bleomycin Vinblastine Dacarbazine Etoposide Cyclophosphamid... Vincristine Procarbazine Prednisone | 18 Years - 75 Years | Harlachinger Krebshilfe e.V. | |
| A Study of N9 Chemotherapy in Children With Neuroblastoma | NCT04947501 | Neuroblastoma Pediatric Cance... | Cyclophosphamid... Topotecan Vincristine Doxorubicin Ifosfamide Etoposide Carboplatin Mesna | 1 Year - 19 Years | Memorial Sloan Kettering Cancer Center | |
| Treatment of Tumors of the Choroid Plexus Epithelium | NCT00500890 | Choroid Plexus ... | Carboplatin Cyclophosphamid... Etoposide Vincristine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia | NCT02776605 | ALL | Prednisone Vincristine Daunorubicin Prednisone Ponatinib Mercaptopurine Methotrexate VP-16 ARA-C: TIT Ponatinib Autologous tran... Allo transplant... | 18 Years - 55 Years | PETHEMA Foundation | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients | NCT00931918 | Non-Germinal B-... | Bortezomib Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisone | 18 Years - | Takeda | |
| Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma | NCT06289673 | Acute Lymphobla... Lymphoblastic L... Mixed Phenotype... | Dexamethasone Vincristine Daunorubicin Intrathecal tri... Methotrexate Cytarabine | 1 Year - 18 Years | St. Jude Children's Research Hospital | |
| Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | NCT01014767 | Brain Cancer Choroid Plexus ... | Carboplatin Cisplatin Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Leucovorin Methotrexate Temozolomide Vincristine | - | Tufts Medical Center | |
| Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | NCT01783535 | Retinoblastoma | vincristine topotecan filgrastim PEG-filgrastim carboplatin focal therapy etoposide cyclophosphamid... MESNA doxorubicin enucleation external beam r... | - | St. Jude Children's Research Hospital | |
| A Study of N9 Chemotherapy in Children With Neuroblastoma | NCT04947501 | Neuroblastoma Pediatric Cance... | Cyclophosphamid... Topotecan Vincristine Doxorubicin Ifosfamide Etoposide Carboplatin Mesna | 1 Year - 19 Years | Memorial Sloan Kettering Cancer Center | |
| A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT03384654 | Precursor Cell ... | Daratumumab Vincristine Prednisone Doxorubicin Peg-asparaginas... Cyclophosphamid... Cytarabine 6-mercaptopurin... Methotrexate | 1 Year - 30 Years | Janssen Research & Development, LLC | |
| Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia | NCT00495079 | Acute Lymphobla... | Marqibo® (vincr... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma | NCT00274924 | Lymphoma | filgrastim rituximab carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide prednisone vincristine | 18 Years - 70 Years | Eastern Cooperative Oncology Group | |
| Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | NCT00126191 | Burkitt Lymphom... Non-Hodgkins Ly... Atypical Burkit... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Methotrexate Leucovorin Ifosfamide Etoposide Cytarabine Mesna | 18 Years - | Dana-Farber Cancer Institute | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma | NCT01974440 | Lymphoma | Bendamustine Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisone PCI-32765 (Ibru... Placebo | 18 Years - | Janssen Research & Development, LLC | |
| Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) | NCT01324180 | Acute Lymphobla... | Metformin Vincristine Dexamethasone PEG-asparaginas... Doxorubicin Intrathecal che... | 1 Year - 30 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma | NCT00284271 | Hodgkin´s Lymph... | Cyclophosphamid... Adramycin Procarbacine Prednisone Vincristine Bleomycin Erythropoietin ... | 61 Years - 75 Years | University of Cologne | |
| R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma | NCT04214626 | Diffuse Large B... | Rituximab Lenalidomide Cyclophosphamid... Epirubicin Vincristine Prednisone Methotrexate | 18 Years - 70 Years | Henan Cancer Hospital | |
| Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage | NCT00890656 | Acute Lymphobla... | Cyclophosphamid... Vincristine Doxorubicin Decadron G-CSF Methotrexate (M... Ara-C Pegaspargase | - | M.D. Anderson Cancer Center | |
| Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study | NCT02894645 | Acute Lymphobla... | Prednisolone Dexamethasone L-Asparaginase Vincristine Methotrexate Daunorubicin Doxorubicin Cyclophosphamid... Cytarabine 6-Mercaptopurin... Thioguanine Fludarabine Imatinib | 1 Year - 17 Years | National University Hospital, Singapore | |
| Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma | NCT06289673 | Acute Lymphobla... Lymphoblastic L... Mixed Phenotype... | Dexamethasone Vincristine Daunorubicin Intrathecal tri... Methotrexate Cytarabine | 1 Year - 18 Years | St. Jude Children's Research Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
